In 2023, the number of multidrug-resistant tuberculosis cases started on treatment in Canada was stable, with 19 cases recorded. Forecasts for 2024 show an increase to 19 cases, continuing with a slight rise to 20 cases by 2025, remaining steady through 2028. The year-on-year growth rate from 2024 is stagnant, indicating minimal variation, with a CAGR of 1.02% projected from 2023 to 2028.
Future trends to watch for include potential impacts of public health interventions and advancements in treatment that could alter case numbers. Monitoring global trends in drug resistance will also be crucial for anticipating changes in forecast accuracy.
